Actual Medicinal Product (AMP) Besavar XL 10mg tablets (Actavis UK Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from moisture. Protect from light. Manufacturer recommends storing in original container. No stability data in MCAs available. Anecdotal reports of use in MCAs for up to 7 days (low quality evidence).
- Provenance
-
This recommendation is based on the products Xatral XL 10mg prolonged release tablets (Sanofi), Besavar XL 10mg tablets (Zentiva) and Vasran XL 10mg prolonged-release tablets (Ranbaxy UK Ltd a Sun Pharmaceutical Company).
- Generic
- Alfuzosin
- Formulation
- Alfuzosin 10mg modified-release tablets
-
Alfuzosin
-
Alfuzosin 10mg modified-release tablets
-
Besavar XL 10mg tablets (Actavis UK Ltd)
-
-
Alfuzosin 2.5mg tablets